Soluble endoglin as a perspective marker of endothelial dysfunction in patients with primary hyperparathyroidism: a pilot study

A. M. Gorbacheva; E. E. Bibik; E. A. Dobreva; A. R. Elfimova; A. K. Eremkina; N. G. Mokrysheva

doi:10.14341/omet12923-10034

For citations:

Gorbacheva A.M., Bibik E.E., Dobreva E.A., Elfimova A.R., Eremkina A.K., Mokrysheva N.G. Soluble endoglin as a perspective marker of endothelial dysfunction in patients with primary hyperparathyroidism: a pilot study. Obesity and metabolism. 2022;19(4):358-368. (In Russ.) https://doi.org/10.14341/omet12923

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Obesity and metabolism

For citations:

Cookies policy